サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439664

機能的電気刺激（FES）装置 - 世界市場の考察、競合情勢、市場予測（2030年）

Functional Electrical Stimulation (FES) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
機能的電気刺激（FES）装置 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の機能的電気刺激（FES）装置の市場規模は、2024年から2030年までの予測期間にCAGRで8.2％の成長が見込まれます。機能的電気刺激（FES）装置の需要の増加は主に、世界中での筋骨格系障害の有病率が上昇によるものです。さらに、疼痛管理治療の重要性の高まりと製品開発における技術革新が、今後数年間のFES市場を活性化させると予測されています。

機能的電気刺激（FES）装置市場力学：

機能的電気刺激（FES）装置市場は、世界中の人々の間で筋骨格系障害の負担が増加しているため、現在勢いを増しています。これは、FES装置が筋肉の可動性を刺激し、筋活動を強化し、筋痙縮を軽減し、筋活動の開始を容易にし、また運動の記憶を提供するためです。例えば、世界保健機関（WHO）が2023年に発表したデータによると、2020年に世界中で合計17億1,000万人が筋骨格系の症状を患っていました。

また、Gov.UK（2020）によると、2020年、英国では18歳以上の人々のうち、長期的な背部痛または長期的な関節痛のいずれかを訴える筋骨格系疾患の割合は18.5％であったと報告されています。また、男性は女性よりも長期的な筋骨格系の問題を訴える割合が低い（それぞれ15.9％、20.9％）です。同様の動向は世界の他の国々でも見られる可能性が高く、FES装置の需要が増加し、世界のFES市場が拡大することが予測されます。

さらに、ターゲット人口に画期的なリハビリテーションケアを提供するためにFES装置を積極的に開発している主要メーカーによる重要な市場拡大活動も、今後数年間のFES市場の潜在的な成長要因となる可能性があります。例えば、2017年12月、Ekso Bionics®はHASOMEDと提携し、EksoGT(TM) Exoskeleton向けの機能的電気刺激（FES）を発売しました。

したがって、上記のすべての要因の相互作用が、予測期間に世界のFES装置市場を押し上げると見込まれます。

しかし、機能的電気刺激（FES）装置に関連するリスクやこれらの装置の高いコストは、市場の成長を妨げる可能性が高いです。

前例のないCOVID-19の発生は、機能的電気刺激（FES）装置市場に大きな影響を与えました。COVID-19が大流行した際、ロックダウン規制が課されたため、患者の受診が減少し、その他すべての外科手術が一時的に中断され、COVID-19に罹患した患者により多くの注意が払われました。しかし、ロックダウン規制の緩和と製造施設の再開により、FES装置市場は平常を取り戻しています。

機能的電気刺激（FES）装置市場セグメント分析：

機能的電気刺激（FES）装置の適応症セグメントでは、神経疾患セグメントが予測期間に大きなシェアを占める見込みです。多発性硬化症、脳卒中などの神経疾患は、FES装置の需要を増加させる可能性が高いです。これは、FES装置が、筋肉を刺激するために軽度の電気パルスを印加する治療法として使用されるためです。多発性硬化症の患者において、FESは筋肉の動きを良くする外部信号を提供します。このように、世界中でターゲット人口が増加しているため、FES装置の市場が拡大する可能性が高いです。例えば、MS International Federationが2020年に発表したデータによると、世界中で約280万人がMSと共に生活しています。

さらに、脳卒中のリハビリテーションにおけるFES装置の有効性を調査するために、企業や研究大学によって行われるさまざまな研究開発や臨床試験も、FES装置市場を急成長させる可能性があります。例えば、Intento SAは、2019年に「重症および中等度の上肢麻痺を伴う慢性脳卒中患者における自己調整機能的電気刺激（SM-FES）」の有効性を研究する臨床試験を開始しました。試験は2022年12月までに完了する予定です。

当レポートでは、世界の機能的電気刺激（FES）装置市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 機能的電気刺激（FES）装置市場レポートのイントロダクション

第2章 機能的電気刺激（FES）装置市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 機能的電気刺激（FES）装置市場の主な要因の分析

  • 機能的電気刺激（FES）装置市場の促進要因
    • 筋骨格系疾患の有病率の増加
    • 疼痛管理治療の重要性の高まり
    • 製品開発における技術革新
  • 機能的電気刺激（FES）装置市場の抑制要因と課題
    • 機能的電気刺激（FES）システムに関連するリスク
    • 機能的電気刺激（FES）装置の高いコスト
  • 機能的電気刺激（FES）装置市場の機会
    • 機能的電気刺激（FES）製品の人気の高まり
    • 新興市場をターゲットにした製品の発売

第5章 機能的電気刺激（FES）装置のポーターのファイブフォース分析

第6章 機能的電気刺激（FES）装置市場に対するCOVID-19の影響分析

第7章 機能的電気刺激（FES）装置の市場レイアウト

  • 製品タイプ別
    • 有線装置
    • 無線装置
  • 適応症別
    • 神経学的障害
    • 疼痛管理
    • 筋骨格系疾患
    • その他
  • エンドユーザー別
    • 病院とクリニック
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 機能的電気刺激（FES）装置：世界の企業シェア分析 - 主要3～5社

第9章 機能的電気刺激（FES）装置の企業と製品のプロファイル

  • HASOMED GmbH
  • Restorative Therapies
  • Bioness Inc.
  • Trulife
  • Otto Bock
  • Odstock Medical Limited
  • Hobbs Rehabilitation
  • MotoMed
  • Medline Industries, LP
  • g.tec medical engineering GmbH

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Functional Electrical Stimulation (FES) Devices Market
  • Table 3: Functional Electrical Stimulation (FES) Devices Market Analysis in Global (2021-2030)
  • Table 4: Functional Electrical Stimulation (FES) Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5: Functional Electrical Stimulation (FES) Devices Market Analysis in Global by Indication (2021-2030)
  • Table 6: Functional Electrical Stimulation (FES) Devices Market Analysis in Global by End User (2021-2030)
  • Table 7: Functional Electrical Stimulation (FES) Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8: Functional Electrical Stimulation (FES) Devices Market Analysis in North America (2021-2030)
  • Table 9: Functional Electrical Stimulation (FES) Devices Market Analysis in North America by Country (2021-2030)
  • Table 10: Functional Electrical Stimulation (FES) Devices Market Analysis in the US (2021-2030)
  • Table 11: Functional Electrical Stimulation (FES) Devices Market Analysis in Canada (2021-2030)
  • Table 12: Functional Electrical Stimulation (FES) Devices Market Analysis in Mexico (2021-2030)
  • Table 13: Functional Electrical Stimulation (FES) Devices Market Analysis in Europe (2021-2030)
  • Table 14: Functional Electrical Stimulation (FES) Devices Market Analysis in Europe by Country (2021-2030)
  • Table 15: Functional Electrical Stimulation (FES) Devices Market Analysis in France (2021-2030)
  • Table 16: Functional Electrical Stimulation (FES) Devices Market Analysis in Germany (2021-2030)
  • Table 17: Functional Electrical Stimulation (FES) Devices Market Analysis in the UK (2021-2030)
  • Table 18: Functional Electrical Stimulation (FES) Devices Market Analysis in Italy (2021-2030)
  • Table 19: Functional Electrical Stimulation (FES) Devices Market Analysis in Spain (2021-2030)
  • Table 20: Functional Electrical Stimulation (FES) Devices Market Analysis in Russia (2021-2030)
  • Table 21: Functional Electrical Stimulation (FES) Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 22: Functional Electrical Stimulation (FES) Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 23: Functional Electrical Stimulation (FES) Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 24: Functional Electrical Stimulation (FES) Devices Market Analysis in China (2021-2030)
  • Table 25: Functional Electrical Stimulation (FES) Devices Market Analysis in Japan (2021-2030)
  • Table 26: Functional Electrical Stimulation (FES) Devices Market Analysis in India (2021-2030)
  • Table 27: Functional Electrical Stimulation (FES) Devices Market Analysis in Australia (2021-2030)
  • Table 28: Functional Electrical Stimulation (FES) Devices Market Analysis in South Korea (2021-2030)
  • Table 29: Functional Electrical Stimulation (FES) Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 30: Functional Electrical Stimulation (FES) Devices Market Analysis in Rest of World (2021-2030)
  • Table 31: Functional Electrical Stimulation (FES) Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 32: Functional Electrical Stimulation (FES) Devices Market Analysis in the Middle East (2021-2030)
  • Table 33: Functional Electrical Stimulation (FES) Devices Market Analysis in Africa (2021-2030)
  • Table 34: Functional Electrical Stimulation (FES) Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Functional Electrical Stimulation (FES) Devices Market
  • Figure 3: Functional Electrical Stimulation (FES) Devices Market Analysis in Global (2021-2030)
  • Figure 4: Functional Electrical Stimulation (FES) Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5: Functional Electrical Stimulation (FES) Devices Market Analysis in Global by Indication (2021-2030)
  • Figure 6: Functional Electrical Stimulation (FES) Devices Market Analysis in Global by End User (2021-2030)
  • Figure 7: Functional Electrical Stimulation (FES) Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8: Functional Electrical Stimulation (FES) Devices Market Analysis in North America (2021-2030)
  • Figure 9: Functional Electrical Stimulation (FES) Devices Market Analysis in North America by Country (2021-2030)
  • Figure 10: Functional Electrical Stimulation (FES) Devices Market Analysis in the US (2021-2030)
  • Figure 11: Functional Electrical Stimulation (FES) Devices Market Analysis in Canada (2021-2030)
  • Figure 12: Functional Electrical Stimulation (FES) Devices Market Analysis in Mexico (2021-2030)
  • Figure 13: Functional Electrical Stimulation (FES) Devices Market Analysis in Europe (2021-2030)
  • Figure 14: Functional Electrical Stimulation (FES) Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 15: Functional Electrical Stimulation (FES) Devices Market Analysis in France (2021-2030)
  • Figure 16: Functional Electrical Stimulation (FES) Devices Market Analysis in Germany (2021-2030)
  • Figure 17: Functional Electrical Stimulation (FES) Devices Market Analysis in the UK (2021-2030)
  • Figure 18: Functional Electrical Stimulation (FES) Devices Market Analysis in Italy (2021-2030)
  • Figure 19: Functional Electrical Stimulation (FES) Devices Market Analysis in Spain (2021-2030)
  • Figure 20: Functional Electrical Stimulation (FES) Devices Market Analysis in Russia (2021-2030)
  • Figure 21: Functional Electrical Stimulation (FES) Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 22: Functional Electrical Stimulation (FES) Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 23: Functional Electrical Stimulation (FES) Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 24: Functional Electrical Stimulation (FES) Devices Market Analysis in China (2021-2030)
  • Figure 25: Functional Electrical Stimulation (FES) Devices Market Analysis in Japan (2021-2030)
  • Figure 26: Functional Electrical Stimulation (FES) Devices Market Analysis in India (2021-2030)
  • Figure 27: Functional Electrical Stimulation (FES) Devices Market Analysis in Australia (2021-2030)
  • Figure 28: Functional Electrical Stimulation (FES) Devices Market Analysis in South Korea (2021-2030)
  • Figure 29: Functional Electrical Stimulation (FES) Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 30: Functional Electrical Stimulation (FES) Devices Market Analysis in Rest of World (2021-2030)
  • Figure 31: Functional Electrical Stimulation (FES) Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 32: Functional Electrical Stimulation (FES) Devices Market Analysis in the Middle East (2021-2030)
  • Figure 33: Functional Electrical Stimulation (FES) Devices Market Analysis in Africa (2021-2030)
  • Figure 34: Functional Electrical Stimulation (FES) Devices Market Analysis in South America (2021-2030)
目次
Product Code: DIMDCL0504

Functional Electrical Stimulation (FES) Devices Market By Product Type (Wired Devices And Wireless Devices), By Indication (Neurological Disorders, Pain Management, Musculoskeletal Disorders, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), by geography, is projected to grow at a noteworthy CAGR forecast till 2030 owing to the rising prevalence of musculoskeletal disorders and technological innovation in product development

The Global Functional Electrical Stimulation Devices Market will grow at a CAGR of 8.2% during the forecast period from 2024 to 2030. The increase in demand for Functional Electrical Stimulation (FES) Devices is primarily due to the rising prevalence of musculoskeletal disorders across the globe. Moreover, the rising importance of pain management therapies and technological innovation in product development is anticipated to fuel the FES market in the upcoming years.

Functional Electrical Stimulation (FES) Devices Market Dynamics:

The market for functional electrical stimulation (FES) devices is gaining propulsion at present owing to the growing burden of musculoskeletal disorders among the population across the globe. This is because FES devices stimulate muscles mobility and strengthen muscle activity, reduce muscle spasticity, facilitate initiation of muscle activity, and also provide a memory of movement. For instance, as per the data published by the World Health Organization (WHO) in the year 2023, a total of 1.71 billion people were suffering from musculoskeletal conditions across the world in the year 2020.

In addition, as per the Gov.UK 2020, in the year 2020, the percentage of people aged 18 and above who reported musculoskeletal condition, either long-term back pain or long-term joint pain was reported to be 18.5% in the United Kingdom. Also, the data mentioned that males remained less likely to report a long-term musculoskeletal problem than females (15.9% and 20.9% respectively) in the United Kingdom in the year 2020. Similar trends are likely to be observed in other countries around the world which are expected to increase the demand for FES devices thereby augmenting the global FES market.

Moreover, key market expansion activities by the key manufacturers actively developing FES devices to provide breakthrough rehabilitative care among the target population could also be a potential factor contributing to the growth of the FES market during the upcoming years. For instance, in December 2017, Ekso Bionics® partnered with HASOMED to launch functional electrical stimulation (FES) for the EksoGT(TM) Exoskeleton.

Thus, the interplay of all the above-mentioned factors is expected to boost the global FES devices market during the forecasted period.

However, the risk associated with functional electrical stimulation devices as well as the high cost of these devices is likely to impede the market growth.

The unprecedented COVID-19 outbreak had a profound impact on the market for functional electrical stimulation (FES) devices. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patient visits and all other surgical procedures were temporarily paused, giving more attention to the COVID-19 inflicted patients. However, after the relaxation given in terms of lockdown restrictions and the re-opening of manufacturing facilities, the FES devices market is regaining normalcy.

Functional Electrical Stimulation (FES) Devices Market Segment Analysis:

Functional Electrical Stimulation (FES) Devices Market By Product Type (Wired Devices and Wireless Devices), By Indication (Neurological Disorders, Pain Management, Musculoskeletal Disorders, and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Functional Electrical Stimulation (FES) Devices indication segment, the neurological disorders segment is anticipated to hold a significant share during the forecasted period. Neurological disorders such as multiple sclerosis, strokes, among others are likely to increase the demand for FES devices. This is because FES devices are used as a treatment that involves the application of mild electrical pulses to stimulate muscles. In patients with multiple sclerosis, FES provides an external signal that makes muscle movement better. Thus, the rising target population across the globe is likely to augment the market for FES devices. For instance, according to the data published by the MS International Federation in the year 2020, approximately 2.8 million people were living with MS worldwide.

Moreover, various R&D and clinical trials conducted by companies and research universities to study the effectiveness of FES devices in stroke rehabilitation could also upsurge the market for FES devices. For instance, Intento SA, initiated a clinical trial to study the efficacy of "Self-modulated Functional Electrical Stimulation in Chronic Stroke Patients with Severe and Moderate Upper Limb Paresis (SM-FES)" in the year 2019. The trial is expected to get complete by December 2022.

Thus, the above-mentioned factors are expected to increase the demand for FES devices for neurological disorders in the forthcoming years.

North America To Dominate the Functional Electrical Stimulation (FES) Devices Market:

Among all the regions, North America is anticipated to dominate the Functional Electrical Stimulation (FES) Devices market during the forecasted period. This is owing to the rising prevalence of the targeted population such as stroke, cerebral palsy, and musculoskeletal disorders, among others. Additionally, the rising obese population in the region could also increase the risk of developing musculoskeletal disorders as well as stroke among the population, leading to an increased demand for FES devices in the upcoming years. Moreover, the presence of key players in the region is one of the factors projected to drive the regional FES market.

Further, in the US, as per the data provided by the U.S Bureau of Labor Statistics 2018, about 272,780 people were suffering from musculoskeletal disorders in the United States private sector. Thus, owing to a rise in musculoskeletal disorders, there will be an increase in the demand for functional electrical stimulation leading to an overall rise in the functional electrical stimulation market.

Moreover, growing cases of chronic pain among the US population could also raise the demand for FES devices thereby bolstering the market. For instance, as per the data published by the Centers for Disease Control and Prevention (CDC) in the year 2020, approximately, 20.4% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities in the US in the year 2019.

In addition, certain strategies like merger & acquisition, getting FDA approval, and new product launches by the manufacturers to maintain their position in the market will also contribute to the regional market growth of FES devices. For instance, on September 21, 2020, Medline Industries, LP received FDA approval for Medline DeNovo 4Pro Electrical Stimulation Device intended to be used for muscle stimulation for urinary incontinence treatment, pain management, muscle strengthening, and training. The device is a TENS (Transcutaneous Electrical Nerve Stimulator), ETS (Electrical Muscle Stimulator), and NMES (Neuromuscular Electrical Stimulator also known as STIM) including FES (Functional Electrical Stimulation) with EMG biofeedback.

Hence, all the aforementioned factors are likely to spur the regional market for FES devices in the forthcoming years.

Functional Electrical Stimulation (FES) Devices Market Key Companies:

Some of the key market players operating in the Functional Electrical Stimulation Devices market include HASOMED GmbH, Restorative Therapies, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Medline Industries, LP, g.tec medical engineering GmbH, and others.

Recent Developmental Activities in the Functional Electrical Stimulation Devices Market:

On October 29, 2020, g.tec medical engineering GmbH received FDA approval for g.Estim FES, neuromuscular electronic stimulator indicated for use under medical supervision for adjunctive therapy in the treatment of medical diseases and conditions.

On March 04, 2020, Bioness Inc. received FDA approval for L100 Go System intended to provide ankle dorsiflexion in adults with foot drop or muscle weakness related to upper motor neuron disease/injury (e.g., stroke, damage to pathways to the spinal cord).

Key Takeaways from the Functional Electrical Stimulation Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Functional Electrical Stimulation (FES) Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Functional Electrical Stimulation (FES) Devices Market.

Various opportunities available for the other competitor in the Functional Electrical Stimulation (FES) Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Functional Electrical Stimulation (FES) Devices market growth in the coming future?

Target Audience who can be benefited from the Functional Electrical Stimulation (FES) Devices Market Report Study

Functional Electrical Stimulation (FES) Devices providers

Research organizations and consulting companies

Functional Electrical Stimulation (FES) Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Functional Electrical Stimulation (FES) Devices

Various End-users who want to know more about the Functional Electrical Stimulation (FES) Devices Market and the latest technological developments in the Functional Electrical Stimulation (FES) Devices market.

Frequently Asked Questions for the Functional Electrical Stimulation (FES) Devices Market:

1. What are Functional Electrical Stimulation (FES) Devices?

Functional electrical stimulation (FES) is a treatment method in which low-level electrical impulses are applied to nerves or muscles to improve or restore muscle function.

2. What is the market for Global Functional Electrical Stimulation (FES) Devices?

The Global Functional Electrical Stimulation Devices Market will grow at a CAGR of 8.2% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Functional Electrical Stimulation (FES) Devices?

The major factor driving the demand for Functional Electrical Stimulation (FES) Devices is the rising prevalence of musculoskeletal disorders across the globe. Moreover, the rising importance of pain management therapies and technological innovation in product development is anticipated to fuel the FES market in the upcoming years.

4. What are the key players operating in Global Functional Electrical Stimulation (FES) Devices?

Some of the key market players operating in the Functional Electrical Stimulation (FES) Devices market include HASOMED GmbH, Restorative Therapies, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Medline Industries, LP, g.tec medical engineering GmbH, and others.

5. Which region has the highest share in the Functional Electrical Stimulation (FES) Devices market?

Among all the regions, North America is anticipated to dominate the Functional Electrical Stimulation (FES) Devices market during the forecasted period. This is owing to the rising prevalence of the targeted population such as stroke, cerebral palsy, and musculoskeletal disorders, among others. Additionally, the rising obese population in the region could also increase the risk of developing musculoskeletal disorders as well as stroke among the population, leading to an increased demand for FES devices in the upcoming years. Moreover, the presence of key players in the region is one of the factors projected to drive the regional FES market.

Table of Contents

1.Functional Electrical Stimulation (FES) Devices Market Report Introduction

2. Functional Electrical Stimulation (FES) Devices Market Executive summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Functional Electrical Stimulation (FES) Devices Market Key factors analysis

  • 4.1. Functional Electrical Stimulation (FES) Devices Market Drivers
    • 4.1.1. Increasing prevalence of musculoskeletal disorders
    • 4.1.2. The rising importance of pain management therapies
    • 4.1.3. Technological Innovation in Product Development
  • 4.2. Functional Electrical Stimulation (FES) Devices Market Restraints and Challenges
    • 4.2.1. Risks associated with Functional Electrical Stimulation systems
    • 4.2.2. High Cost of the Functional Electrical Stimulation Devices
  • 4.3. Functional Electrical Stimulation (FES) Devices Market Opportunities
    • 4.3.1. Rising Popularity of Functional Electrical Stimulation Products
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Functional Electrical Stimulation (FES) Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Functional Electrical Stimulation (FES) Devices Market

7. Functional Electrical Stimulation (FES) Devices Market layout

  • 7.1. By Product Type
    • 7.1.1. Wired Devices
    • 7.1.2. Wireless Devices
  • 7.2. By Indication
    • 7.2.1. Neurological Disorders
    • 7.2.2. Pain Management
    • 7.2.3. Musculoskeletal Disorders
    • 7.2.4. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Functional Electrical Stimulation (FES) Devices Market, by Country
      • 7.4.1.1.1. United States
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Functional Electrical Stimulation (FES) Devices Market, by Country
      • 7.4.2.1.1. France
      • 7.4.2.1.2. Germany
      • 7.4.2.1.3. United Kingdom
      • 7.4.2.1.4. Italy
      • 7.4.2.1.5. Spain
      • 7.4.2.1.6. Russia
      • 7.4.2.1.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Functional Electrical Stimulation (FES) Devices Market, by Country
      • 7.4.3.1.1. China
      • 7.4.3.1.2. Japan
      • 7.4.3.1.3. India
      • 7.4.3.1.4. Australia
      • 7.4.3.1.5. South Korea
      • 7.4.3.1.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Functional Electrical Stimulation (FES) Devices Market, by Region
      • 7.4.4.1.1. Middle East
      • 7.4.4.1.2. Africa
      • 7.4.4.1.3. South America

8. Functional Electrical Stimulation (FES) Devices Global Company Share Analysis - Key 3-5 Companies

9. Functional Electrical Stimulation (FES) Devices Company and Product Profiles

  • 9.1. HASOMED GmbH
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Restorative Therapies
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Bioness Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Trulife
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Otto Bock
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Odstock Medical Limited
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Hobbs Rehabilitation
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. MotoMed
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Medline Industries, LP
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. g.tec medical engineering GmbH
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us